SCHEMBL6275840

SCHEMBL6275840

CCOc1c(O)c2cc(OCCCC(=O)O)ccc2oc1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACSL1 P33121 2/20 0.53
▸ ACSL6 Q9UKU0 2/20 0.53
▸ KDM4E B2RXH2 6/20 0.46
▸ FFAR1 O14842 2/20 0.46
▸ FFAR4 Q5NUL3 2/20 0.46
▸ NQO1 P15559 1/20 0.44
▸ ALDH2 P05091 1/20 0.43
▸ MAOA P21397 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.43
▸ HPGD P15428 5/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ SCP2 P22307 1/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ GAA P10253 2/20 0.42
▸ MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6270819 0.97 ACSL1 (0.57) ACSL1ACSL6KDM4EFFAR1FFAR4
SCHEMBL6276260 0.94 ACSL1 (0.48) ACSL1ACSL6KDM4ENQO1ALDH1A1
SCHEMBL6277212 0.93 ACSL1 (0.53) ACSL1ACSL6KDM4ENQO1ALDH2
SCHEMBL6270593 0.91 ALDH2 (0.51) ACSL1ACSL6KDM4EFFAR1FFAR4
SCHEMBL6273083 0.90 ACSL1 (0.54) ACSL1ACSL6ALDH2MAOAMAOB
SCHEMBL6270759 0.90 ACSL1 (0.54) ACSL1ACSL6ALDH2MAOAMAOB
SCHEMBL6276243 0.90 ACSL1 (0.57) ACSL1ACSL6KDM4ENQO1ALDH2
SCHEMBL27563415 0.89 ACSL1 (0.58) ACSL1ACSL6NQO1ALDH2MAOA
SCHEMBL6274684 0.89 ACSL1 (0.50) ACSL1ACSL6KDM4ENQO1ALDH2
SCHEMBL6277207 0.88 ACSL1 (0.57) ACSL1ACSL6ALDH2MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
CN-1473565-A Benzopyrany/derivatives and antiallergic agent ���ձ���ī��ѧ��ʽ���� 2004-02-11 — — CN disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 ACSL1 1912/4885ACSL6 2711/4885KDM4E 965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback